Combined therapy with rituximab plus cyclophosphamide/doxorubicin/vincristine/prednisone (CHOP) for Sjögren's syndrome-associated B-cell aggressive non-Hodgkin's lymphomas. [electronic resource]
Producer: 20040830Description: 1050-3 p. digitalISSN:- 1462-0324
- Adult
- Antibodies, Monoclonal -- adverse effects
- Antibodies, Monoclonal, Murine-Derived
- Antigens, CD -- analysis
- Antineoplastic Agents -- adverse effects
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- B-Lymphocytes -- immunology
- Cryoglobulinemia -- etiology
- Cyclophosphamide -- adverse effects
- Doxorubicin -- adverse effects
- Drug Therapy, Combination
- Humans
- Lymphoma, B-Cell -- drug therapy
- Middle Aged
- Prednisone -- adverse effects
- Rituximab
- Sjogren's Syndrome -- complications
- Treatment Outcome
- Vincristine -- adverse effects
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.